-
Glass J, Won M, Schultz CJ, Brat D, et al.
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and
Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation
Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. J Clin Oncol 2016.
-
Del Trigo M, Bergeron S, Bernier M, Amat-Santos IJ, et al.
Unidirectional left-to-right interatrial shunting for treatment of patients with
heart failure with reduced ejection fraction: a safety and proof-of-principle
cohort study. Lancet 2016;387:1290-7.
-
Hasenfuss G, Hayward C, Burkhoff D, Silvestry FE, et al.
A transcatheter intracardiac shunt device for heart failure with preserved
ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1
trial. Lancet 2016;387:1298-304.
-
Plowden TC, Schisterman EF, Sjaarda LA, Zarek SM, et al.
Subclinical hypothyroidism and thyroid autoimmunity are not associated with
fecundity, pregnancy loss or live birth. J Clin Endocrinol Metab 2016.
-
Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P, et al.
Pathological alpha-synuclein in gastrointestinal tissues from prodromal
parkinson's disease patients. Ann Neurol 2016.
|